Cleveland BioLabs and Incuron Announce Poster Presentation at Cell Symposia: Cancer Epigenomics
02 oct. 2013 07h30 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster...
Cleveland BioLabs Secures $10 Million Loan Agreement With Hercules Technology Growth Capital
01 oct. 2013 08h36 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) announced today it has closed on a loan and security agreement with Hercules Technology Growth Capital, Inc....
Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 European Cancer Congress
19 sept. 2013 08h00 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Sept. 19, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster...
Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 ASCP Annual Meeting
12 sept. 2013 07h30 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster...
Cleveland BioLabs Reports Second Quarter 2013 Financial Results and Development Progress
13 août 2013 07h00 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported financial results and development progress for the second quarter and six-month periods ended June...
Cleveland BioLabs and Incuron Announce Start of US Trial With CBL0137
07 août 2013 08h00 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced that a...
Cleveland BioLabs to Report Second Quarter 2013 Financial Results and Provide Operational Update on August 13
01 août 2013 08h00 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced that on August 13, 2013 before the market opens, it will report its financial results for the...
Cell Reports Publication Elucidates Role of FACT as Accelerator of Tumor Transformation and Potential Marker and Target of Aggressive Cancers
08 juil. 2013 07h00 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., July 8, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI), Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, and Roswell Park Cancer Institute...
Cleveland BioLabs and Incuron Announce Poster Presentation at ESMO 15th World Congress on Gastrointestinal Cancer
25 juin 2013 07h30 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., June 25, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures, today announced a poster...
Cleveland BioLabs and Incuron Announce US and European Patent Allowances for Curaxins
14 mai 2013 07h30 HE
|
Cleveland BioLabs, Inc.
BUFFALO, N.Y., May 14, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced the receipt...